Target intelligence / Profile preview

FGFBP3 antisense RNA 1 (FGFBP3-AS1)

Target: FGFBP3-AS1
Molecular classification: Non-coding RNA, Antisense RNA

Overview

FGFBP3 antisense RNA 1 (FGFBP3-AS1) is a non-coding RNA gene transcribed antisense to the protein-coding FGFBP3 gene. While the exact function of FGFBP3-AS1 is not defined in current databases or literature, antisense RNAs typically function by modulating the expression or stability of their sense counterparts (in this case, FGFBP3). There are no reports of FGFBP3-AS1 as a therapeutic target, biomarker, or drug-interaction candidate[3]. Key distinctions: FGFBP3-AS1 should not be confused with FGFBP3, which is a secreted protein involved in fibroblast growth factor signaling, metabolic regulation, and associated with various metabolic and neuromuscular diseases[1][5]. FGFBP3-AS1 is not currently a recognized therapeutic target.

Other names: FGFBP3-AS1

Mechanism of action

None (no mechanism of action reported for FGFBP3-AS1-targeting drugs, if any)

Biological functions

Unknown (no specific biological function described for FGFBP3-AS1; generally, antisense RNAs may regulate expression of their sense counterparts)

Disease associations

Unknown (no diseases directly associated with FGFBP3-AS1 reported in the accessible sources)

Beyond the preview

Go deeper on FGFBP3 antisense RNA 1 (FGFBP3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FGFBP3 antisense RNA 1 (FGFBP3-AS1).

Explore the full profile